Recursion Pharmaceuticals, Inc. (RXRX)

CIK 1601830 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Recursion Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001601830-26-000151
Nov 4, 202640001601830-26-000150
Nov 4, 202630001601830-26-000149
Nov 3, 20261440001959173-26-007679
Nov 2, 202610-Q0001601830-26-000145
Nov 2, 20268-K0001601830-26-000144
Oct 15, 2026424B50001601830-26-000134
Oct 15, 20268-K0001601830-26-000128
Oct 15, 2026424B50001601830-26-000126
Oct 7, 202640001601830-26-000119
Oct 7, 202640001601830-26-000120
Oct 6, 20261440001959173-26-007282
Oct 6, 20261440001959173-26-007281
Oct 2, 202640001601830-26-000116
Oct 2, 202640001601830-26-000115
Sep 21, 20268-K0001601830-26-000112
Sep 16, 202640001601830-26-000110
Sep 10, 202640001601830-26-000105
Sep 8, 20261440001628280-26-060859
Sep 2, 202640001601830-26-000103
Sep 1, 20261440001959173-26-006610
Aug 21, 20261440001959173-26-006306
Aug 20, 20261440001959173-26-006256
Aug 19, 20261440001959173-26-006204
Aug 18, 20261440001959173-26-006192